1. Home
  2. ENVA vs ARQT Comparison

ENVA vs ARQT Comparison

Compare ENVA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$134.21

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$22.75

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
ARQT
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
ENVA
ARQT
Price
$134.21
$22.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$173.00
$31.86
AVG Volume (30 Days)
247.3K
1.2M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
88.79
EPS
11.52
N/A
Revenue
$3,151,653,000.00
$376,072,000.00
Revenue This Year
$149.91
$34.46
Revenue Next Year
$15.38
$29.77
P/E Ratio
$11.72
N/A
Revenue Growth
18.58
91.34
52 Week Low
$79.41
$11.86
52 Week High
$176.68
$31.77

Technical Indicators

Market Signals
Indicator
ENVA
ARQT
Relative Strength Index (RSI) 36.78 35.75
Support Level $115.35 $22.56
Resistance Level $149.49 $27.26
Average True Range (ATR) 5.39 1.26
MACD -0.34 -0.26
Stochastic Oscillator 4.11 3.25

Price Performance

Historical Comparison
ENVA
ARQT

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: